Pfizer's talazoparib extends PFS in phase III trial in metastatic breast cancer

How AI will transform mental health support for breast cancer patients, narrative review paper details

Researchers from UVA Cancer Center, the University of Virginia School of Medicine, and Inova Peterson Life with Cancer detail the many ways artificial intelligence could help ensure patients receive the support they need.

September 19, 2025

Vol.51 No.34

In Brief

VCU Massey, MD Anderson researchers awarded $7.3M grant to launch breast cancer clinical trial

Venkata Lokesh BattulaClinton YamA multidisciplinary team of researchers at VCU Massey Comprehensive Cancer Center and MD Anderson Cancer Center has been awarded a $7.3 million grant from the U.S. Department of Defense to fund a novel clinical trial targeting one of the most aggressive and hard-to-treat forms of breast cancer: metastatic triple-negative breast cancer.

September 12, 2025

Vol.51 No.33

Clinical Roundup

MammaPrint predicts chemotherapy benefit in HR+HER2 early breast cancer patients, observational FLEX study finds

The MammaPrint, a gene expression profiling test, predicts the benefit of chemotherapy for patients with hormone receptor-positive, HER2-negative early-stage breast cancer, according to findings published in JNCI Cancer Spectrum.

September 05, 2025

Vol.51 No.32

Cancer Policy

ACOG says it will no longer accept federal funding

The American College of Obstetrics and Gynecology said it will no longer be accepting federal funding.

August 08, 2025

Vol.51 No.31

By Claire Marie Porter

In Brief

Antonio Wolff, Mikala Egeblad named co-directors of Johns Hopkins Kimmel Cancer Center Breast and Gynecologic Cancer Program

Antonio WolffMikala EgebladAntonio C. Wolff and Mikala Egeblad were named co-directors of the Breast and Gynecologic Cancer Program at Johns Hopkins Kimmel Cancer Center.

August 08, 2025

Vol.51 No.31